Abstract
Background
N-chlorotaurine (NCT), an endogenous mild antiseptic, is well-tolerated by application to the human conjunctiva and has been shown to offer beneficial effects in infectious conjunctivitis. Animal tests revealed improved efficacy of a combination of NCT with ammonium chloride in adenoviral conjunctivitis. The aim of this study was to evaluate the tolerability of NCT plus ammonium chloride in the healthy rabbit and human eye.
Methods
First, a tolerability study was performed in rabbits. In a blinded and randomized fashion, one eye was treated with the test medication, the other one with 0.9% saline. Twenty-one animals (three per concentration) were treated with one drop every 2 hours for 6 days. Second, in two volunteers one drop of a defined concentration was applied to one eye every 15 min for 1 hour, saline to the control eye. Four different concentrations were tested on different days. Third, a double-blind, randomized phase 1 study in 13 healthy volunteers was performed. One drop of 0.1% NCT plus 0.1% NH4Cl versus saline was applied every 15 min within the first hour, followed by four drops every 2 hours. This regimen was done daily for 5 days.
Results
In rabbits, no side effects were seen with 0.1% NCT plus 0.1% NH4Cl, while higher concentrations sometimes caused short-time and minimal conjunctival injection and secretion after dosing. By 1% NCT plus 1% NH4Cl, these effects were moderate, but disappeared again without any detectable residues. In the pilot study with two volunteers, treatment with 0.5% NCT plus 0.1% NH4Cl caused medium-scale eye burning for 30 seconds, while 0.1% NCT plus 0.1% NH4Cl was very well-tolerated, with no or minimal burning for a few seconds. In the subsequent phase 1 study, 0.1% NCT plus 0.1% NH4Cl was well-tolerated by all subjects except for minimal eye burning for a few seconds after dropping. No objective signs of eye changes could be detected in the human beings.
Conclusion
The results of this study clearly demonstrate the good tolerability of a promising NCT formulation with improved activity.
Similar content being viewed by others
References
Gottardi W, Arnitz R, Nagl M (2007) N-chlorotaurine and ammonium chloride: an antiseptic preparation with strong bactericidal activity. Int J Pharm 335:32–40, doi:10.1016/j.ijpharm.2006.11.003
Gottardi W, Nagl M (2002) Chemical properties of N-chlorotaurine sodium, a key compound in the human defence system. Arch Pharm Pharm Med Chem 335:411–421, doi:10.1002/1521-4184(200212)335:9<411::AID-ARDP411>3.0.CO;2-D
Grisham MB, Jefferson MM, Melton DF, Thomas EL (1984) Chlorination of endogenous amines by isolated neutrophils. J Biol Chem 259:10404–10413
Jauch A, Fsadni M, Gamba G (1999) Meta-analysis of six clinical phase III studies comparing lomefloxacin 0.3% eye drops twice daily to five standard antibiotics in patients with acute bacterial conjunctivitis. Graefes Arch Clin Exp Ophthalmol 237:705–713, doi:10.1007/s004170050300
Kinchington PR, Romanowski EG, Gordon YJ (2005) Prospects for adenovirus antivirals. J Antimicrob Chemother 55:424–429, doi:10.1093/jac/dki057
Nagl M, Gottardi W (1992) In vitro experiments on the bactericidal action of N-chlorotaurine. Hyg Med 17:431–439
Nagl M, Gottardi W (1996) Enhancement of the bactericidal efficacy of N-chlorotaurine by inflammation samples and selected N-H compounds. Hyg Med 21:597–605
Nagl M, Gottardi W (1998) Rapid killing of Mycobacterium terrae by N-chlorotaurine in presence of ammonium is caused by the reaction product monochloramine. J Pharm Pharmacol 50:1317–1320
Nagl M, Gruber A, Fuchs A, Lell C, Lemberger EM, Borg-von Zepelin M et al (2002) Impact of N-chlorotaurine on viability and production of secreted aspartyl proteinases of Candida spp. Antimicrob Agents Chemother 46:1996–1999, doi:10.1128/AAC.46.6.1996-1999.2002
Nagl M, Hengster P, Semenitz E, Gottardi W (1999) The postantibiotic effect of N-chlorotaurine on Staphylococcus aureus. Application in the mouse peritonitis model. J Antimicrob Chemother 43:805–809, doi:10.1093/jac/43.6.805
Nagl M, Hess M, Pfaller K, Hengster P, Gottardi W (2000) Bactericidal activity of micromolar N-chlorotaurine - evidence for its antimicrobial function in the human defence system. Antimicrob Agents Chemother 44:2507–2513, doi:10.1128/AAC.44.9.2507-2513.2000
Nagl M, Larcher C, Gottardi W (1998) Activity of N-chlorotaurine against herpes simplex- and adenoviruses. Antiviral Res 38:25–30, doi:10.1016/S0166-3542(98)00005-9
Nagl M, Lass-Floerl C, Neher A, Gunkel AR, Gottardi W (2001) Enhanced fungicidal activity of N-chlorotaurine in nasal secretion. J Antimicrob Chemother 47:871–874, doi:10.1093/jac/47.6.871
Nagl M, Miller B, Daxecker F, Ulmer H, Gottardi W (1998) Tolerance of N-chlorotaurine, an endogenous antimicrobial agent, in the rabbit and human eye - a phase I clinical study. J Ocul Pharmacol Ther 14:283–290
Nagl M, Nguyen VA, Gottardi W, Ulmer H, Höpfl R (2003) Tolerability and efficacy of N-chlorotaurine compared to chloramine T for treatment of chronic leg ulcers with purulent coating. Br J Dermatol 149:590–597, doi:10.1046/j.1365-2133.2003.05432.x
Nagl M, Pfausler B, Schmutzhard E, Fille M, Gottardi W (1998) Tolerance and bactericidal action of N-chlorotaurine in a urinary tract infection by an omniresistant Pseudomonas aeruginosa. Zentralbl Bakteriol 288:217–223
Nagl M, Teuchner B, Pöttinger E, Ulmer H, Gottardi W (2000) Tolerance of N-chlorotaurine, a new antimicrobial agent, in infectious conjunctivitis - a phase II pilot study. Ophthalmologica 214:111–114, doi:10.1159/000027477
Neher A, Fischer H, Appenroth E, Lass-Floerl C, Mayr A, Gschwendtner A et al (2005) Tolerability of N-Chlorotaurine in Chronic Rhinosinusitis Applied via Yamik Catheter. Auris Nasus Larynx 32:359–364, doi:10.1016/j.anl.2005.05.006
Neher A, Nagl M, Appenroth E, Gstottner M, Wischatta M, Reisigl F et al (2004) Acute Otitis Externa: Efficacy and Tolerability of N-Chlorotaurine, a Novel Endogenous Antiseptic Agent. Laryngoscope 114:850–854, doi:10.1097/00005537-200405000-00011
Notivol R, Martinez M, Bergamini MV (1994) Treatment of chronic nonbacterial conjunctivitis with a cyclo-oxygenase inhibitor or a corticosteroid. Pranoprofen Study Group. Am J Ophthalmol 117:651–656
Rand MC, Greenberg AE, Taras MJ (1979) Iodometric method I. In: Rand MC, Greenberg AE, Taras MJ (eds) Standard methods for examination of water and wastewater. American Public Health Association, Washington DC, pp 316–318
Romanowski EG, Yates KA, Teuchner B, Nagl M, Gottardi W, Gordon YJ (2002) In vitro evaluation of the new antimicrobial agent N-chlorotaurine (NCT) against ocular isolates of adenovirus. Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO); 5 May 2002, Fort Lauderdale, Florida
Romanowski EG, Yates KA, Teuchner B, Nagl M, Irschick EU, Gordon YJ (2006) N-Chlorotaurine is an effective antiviral agent against adenovirus in vitro and in the Ad5/NZW rabbit ocular model. Invest Ophthalmol Vis Sci 47:2021–2026, doi:10.1167/iovs.05-1270
Stelmaszynska T, Zgliczynski JM (1974) Myeloperoxidase of human neutrophilic granulocytes as chlorinating enzyme. Eur J Biochem 45:305–312, doi:10.1111/j.1432-1033.1974.tb03555.x
Teuchner B, Nagl M, Schidlbauer A, Ishiko H, Dragosits E, Ulmer H et al (2005) Tolerability and efficacy of N-chlorotaurine in epidemic keratoconjunctivitis - a double-blind randomized phase 2 clinical trial. J Ocul Pharmacol Ther 21:157–165, doi:10.1089/jop.2005.21.157
Unterberger I, Spiss H, Brandauer E, Engelhardt K, Pfausler B, Kampfl A et al (2001) N-chlorotaurine - local antibacterial therapy in urinary tract infections by omniresistant Pseudomonas aeruginosa. Twenty-First Annual Conference of the Arbeitsgemeinschaft Neurologische Intensivmedizin (ANIM); 18 Jan 2001, Innsbruck, Austria
Acknowledgements
Patient insurance was provided by the Tiroler Landeskrankenanstalten GmbH (TILAK, Innsbruck, Austria). We thank Jeffrey Nau, MMS, Denis O’Shaughnessy, PhD, and Nathan R.F. Beeley, PhD (Opko Ophthalmics, Miami, USA) for their support.
Clinical trial registration
EudraCT number 2006-002701-32
Animal tests approval no. GZ 66.011/79-BrGT/2003 (Austrian Federal Government of Science and Research).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Teuchner, B., Schmid, E., Ulmer, H. et al. Tolerability of N-chlorotaurine plus ammonium chloride in the rabbit and human eye - a phase 1 clinical study. Graefes Arch Clin Exp Ophthalmol 246, 1723–1730 (2008). https://doi.org/10.1007/s00417-008-0900-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-008-0900-x